Figure 1From: Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veteransAdjuvant chemotherapy regimen received in thefirst cycleby year of pathology confirmed diagnosis. “Other” includes 3 patients who received an oxaliplatin-based regimen plus bevacizumab; 6 patients who received an irinotecan-based regimen, and 2 patients who received a regimen not listed.Back to article page